Suppr超能文献

神经疾病中的大麻素。

Cannabinoids in Neurologic Illnesses.

机构信息

Neurology, Nationwide Children's Hospital, The Ohio State University College of Medicine, FOB 41.55, 700 Children's Drive, Columbus, OH 43205, USA.

出版信息

Neurol Clin. 2021 Feb;39(1):231-241. doi: 10.1016/j.ncl.2020.09.012. Epub 2020 Nov 7.

Abstract

Marijuana has been used to treat medical disease since well before the 1800s. Recently, increased use of cannabinoids, the chemical components of marijuana, have been seen to treat neurologic illness in children and adults. Unfortunately, data are lacking in treating most neurologic illnesses except in the field of epilepsy and pain from spasticity in multiple sclerosis. Therefore, formal conclusions about the potential efficacy, benefit, and adverse effects for most marijuana based products cannot be made at this time. Further research using gold standard scientific methodology should be performed to help address potential uses and safety for cannabinoids to treat neurologic illnesses.

摘要

大麻自 19 世纪以来就被用于治疗医学疾病。最近,大麻的化学成分大麻素的使用增加,被用于治疗儿童和成人的神经疾病。不幸的是,除了在癫痫和多发性硬化症痉挛性疼痛领域外,治疗大多数神经疾病的数据都缺乏。因此,目前无法对大多数基于大麻的产品的潜在疗效、益处和不良反应做出正式结论。应使用黄金标准科学方法进行进一步研究,以帮助确定大麻素治疗神经疾病的潜在用途和安全性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验